| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |